A detailed history of Investment Research & Advisory Group, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Investment Research & Advisory Group, Inc. holds 43 shares of VTRS stock, worth $446. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43
Previous 156 72.44%
Holding current value
$446
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

SELL
$8.74 - $10.69 $987 - $1,207
-113 Reduced 72.44%
43 $0
Q2 2025

Jul 17, 2025

BUY
$7.26 - $9.12 $675 - $848
93 Added 147.62%
156 $1,000
Q1 2025

Apr 21, 2025

BUY
$8.68 - $12.42 $373 - $534
43 Added 215.0%
63 $0
Q4 2022

Jan 31, 2023

BUY
$8.72 - $11.56 $174 - $231
20 New
20 $0

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Investment Research & Advisory Group, Inc. Portfolio

Follow Investment Research & Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Research & Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Investment Research & Advisory Group, Inc. with notifications on news.